Disclosed herein are substituted cyclohexanone-based NMDA receptor modulators of Formula I, process of preparation thereof, pharmaceutical compositions thereof, and methods of use thereof.
本文揭示了基于取代环己酮的Formula I NMDA受体调节剂,其制备方法,相应的药物组合物以及使用方法。
NAMPT INHIBITORS
申请人:AbbVie Inc.
公开号:US20170065575A1
公开(公告)日:2017-03-09
Disclosed are compounds which inhibit the activity of NAMPT, compositions containing the compounds and methods of treating diseases during which NAMPT is expressed.
PYRIDAZINE AND PYRIDINE DERIVATIVES AS NAMPT INHIBITORS
申请人:AbbVie Inc.
公开号:EP2847181A1
公开(公告)日:2015-03-18
US8975398B2
申请人:——
公开号:US8975398B2
公开(公告)日:2015-03-10
[EN] PYRIDAZINE AND PYRIDINE DERIVATIVES AS NAMPT INHIBITORS<br/>[FR] DÉRIVÉS DE PYRIDAZINE ET PYRIDINE EN TANT QU'INHIBITEURS DE NAMPT
申请人:ABBVIE INC
公开号:WO2013170115A1
公开(公告)日:2013-11-14
Disclosed are compounds of formula (IC), or a therapeutically acceptable salt thereof which inhibit the activity of NAMPT, compositions containing the compounds and methods of treating diseases during which NAMPT is expressed.